2027 Medicare OPPS and ASC Payment Changes: What Outpatient Providers Need to Know
Medicare outpatient reimbursement is changing in 2027, creating important billing and operational considerations for hospitals, ambulatory surgery centers (ASCs), and other outpatient healthcare providers.
The Centers for Medicare & Medicaid Services (CMS) finalized the Calendar Year 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System rule in November 2026. The final rule updates outpatient payment rates, expands the list of procedures eligible for outpatient settings, changes reimbursement for certain 340B-acquired drugs, and introduces additional billing and administrative requirements.
For outpatient facilities, these updates can influence reimbursement calculations, procedure scheduling, coding, claim submission, and revenue cycle management.
Understanding the finalized policies before their effective dates can help healthcare organizations update billing systems, train staff, and reduce avoidable reimbursement problems.
This guide explains the major 2027 Medicare OPPS and ASC changes and the practical steps outpatient providers should take to prepare.
What Are the 2027 Medicare OPPS and ASC Payment Changes?
The Medicare Hospital Outpatient Prospective Payment System determines how Medicare reimburses eligible hospital outpatient departments for covered services.
The ASC Payment System establishes payment rates for covered surgical procedures and certain related services furnished in Medicare-certified ambulatory surgery centers.
CMS updates both payment systems annually to account for changes in healthcare costs, service utilization, clinical practices, and other payment considerations.
The CY 2027 final rule introduces several important updates:
-
A 2.3% payment rate update for qualifying OPPS hospitals and ASCs.
-
Revised reimbursement for certain 340B-acquired outpatient drugs.
-
Expanded site-neutral payment policies for imaging services.
-
Removal of 637 services from the Medicare Inpatient Only list.
-
Addition of 618 codes to the ASC Covered Procedures List.
-
Expanded prior authorization requirements for certain botulinum toxin injection codes.
-
Additional administrative requirements for off-campus hospital outpatient departments.
Most payment changes take effect January 1, 2027, while certain requirements have later effective dates.
7 Major Medicare OPPS and ASC Changes for 2027
1. Medicare OPPS and ASC Payment Rates Increase by 2.3%
CMS finalized a 2.3% payment update for qualifying hospital outpatient departments and ambulatory surgery centers that meet applicable quality reporting requirements.
The update is based on:
-
A 3.2% projected hospital market basket increase.
-
A 0.9 percentage-point productivity adjustment.
The resulting 2.3% update applies to the relevant OPPS and ASC payment calculations.
For outpatient facilities, this adjustment can influence expected reimbursement for eligible services and procedures.
However, a 2.3% rate update does not mean every facility or procedure will receive exactly 2.3% more reimbursement. Actual payment depends on the applicable payment classification, procedure, geographic adjustments, quality reporting status, and other finalized policies.
Facilities should review their service mix and updated Medicare payment files rather than applying the general update uniformly to all claims.
2. Medicare Changes Reimbursement for Certain 340B-Acquired Drugs
One of the most significant changes involves Medicare payment for separately payable outpatient drugs acquired through the 340B Drug Pricing Program.
Beginning in 2027, CMS will reimburse applicable 340B-acquired drugs at:
Average Sales Price (ASP) minus 28%.
Previously, these drugs were generally reimbursed at ASP plus 6%.
The finalized policy is intended to align Medicare payments more closely with the acquisition costs of qualifying drugs.
Certain facilities and drug categories are exempt from the reduction under the finalized policy. These include specified children's hospitals, rural sole community hospitals, PPS-exempt cancer hospitals, and qualifying drug categories.
The policy also includes a budget-neutral adjustment to payments for other outpatient services.
For hospitals participating in the 340B program, this change requires particular attention to drug acquisition records, billing configurations, and reimbursement reconciliation.
Facilities should review:
-
Which drugs are subject to the payment reduction.
-
Which facilities and drug categories qualify for exemptions.
-
Whether drug acquisition status is correctly documented.
-
Whether the appropriate claim modifiers are applied.
-
Whether expected reimbursement matches Medicare remittance information.
Accurate drug billing is essential because incorrect acquisition-status reporting can create payment discrepancies and compliance concerns.
3. New Site-Neutral Payment Rules for Certain Imaging Services
CMS is expanding its site-neutral payment policy to include certain imaging services furnished in excepted off-campus hospital provider-based departments.
The policy applies to imaging services without contrast, including applicable:
-
X-rays.
-
Ultrasounds.
-
CT scans.
-
MRI services.
-
Bone density scans.
For affected services, Medicare will use the applicable Physician Fee Schedule equivalent payment rate instead of the higher OPPS rate.
Rural Sole Community Hospitals are exempt from this particular policy.
CMS estimates that the change will reduce Medicare Part B expenditures by approximately $260 million in its first year.
For affected hospital outpatient departments, the policy may change reimbursement expectations for imaging services.
Facilities should identify the applicable imaging codes, confirm whether their locations fall within the policy's scope, and update reimbursement estimates accordingly.
Billing teams should also ensure that claims reflect the correct service location and applicable payment methodology.
4. CMS Removes 637 Services From the Inpatient Only List
CMS is continuing its multi-year phaseout of the Medicare Inpatient Only (IPO) list.
For 2027, the agency finalized the removal of 637 services from the list.
This change allows the affected services to become eligible for Medicare payment in hospital outpatient settings when the applicable coverage and clinical requirements are satisfied.
The removed services span several clinical families, including:
-
Auditory.
-
Digestive.
-
Endocrine.
-
Female genital.
-
Hemic and lymphatic systems.
-
Integumentary.
-
Male genital.
-
Maternity care and delivery.
-
Mediastinum and diaphragm.
-
Respiratory.
-
Urinary.
The removal of a procedure from the IPO list does not automatically mean every patient should receive that procedure in an outpatient setting.
Providers must still determine the clinically appropriate setting based on the patient's condition, procedure complexity, and applicable Medicare requirements.
Hospitals should review the affected procedure codes, assess outpatient capabilities, and update their scheduling, authorization, coding, and billing workflows.
5. CMS Adds 618 Codes to the ASC Covered Procedures List
The 2027 final rule expands the Medicare ASC Covered Procedures List by adding 618 codes.
This expansion includes codes recommended by stakeholders and procedures removed from the Inpatient Only list for 2027.
The change creates additional opportunities for eligible surgical procedures to be furnished in ambulatory surgery centers.
For ASC operators, expanded procedure eligibility may influence:
-
Service-line planning.
-
Surgical scheduling.
-
Equipment and staffing requirements.
-
Medicare reimbursement forecasting.
-
Physician contracting.
-
Patient financial responsibility.
-
Coding and claim submission.
However, inclusion on the ASC Covered Procedures List does not automatically establish that every patient or every clinical circumstance qualifies for ASC treatment.
Facilities must continue evaluating Medicare coverage conditions, patient suitability, applicable safety requirements, and payment policies.
ASC billing teams should also verify the correct procedure codes and payment classifications before submitting claims.
6. Prior Authorization Expands to Certain Botulinum Toxin Injections
CMS finalized an expansion of the existing Medicare hospital outpatient prior authorization program to include applicable botulinum toxin injection codes.
The new requirement applies to dates of service on or after July 1, 2027.
For affected outpatient hospitals, this means authorization workflows must account for the additional services before the effective date.
Facilities should:
-
Identify the affected procedure codes.
-
Review the applicable Medicare authorization requirements.
-
Update scheduling and authorization procedures.
-
Train staff responsible for submitting requests.
-
Maintain supporting clinical documentation.
-
Track authorization decisions and reference numbers.
-
Verify that submitted claims match approved services.
Authorization approval does not guarantee reimbursement. Claims must still satisfy applicable Medicare coverage, coding, documentation, and billing requirements.
An organized authorization process can help reduce preventable delays and claims denied for missing or incorrect authorization information.
7. New NPI and Attestation Requirements for Off-Campus Departments
CMS finalized additional requirements for off-campus hospital provider-based departments.
Beginning January 1, 2028, each applicable off-campus outpatient department must obtain a separate National Provider Identifier (NPI) and attest to compliance with provider-based requirements as a condition for Medicare payment under the applicable policy.
Although this requirement does not begin in 2027, affected hospitals should start preparing during the upcoming implementation period.
Administrative teams should review their off-campus locations, provider-based status, NPI records, and Medicare enrollment information.
Facilities should coordinate these preparations across compliance, enrollment, billing, and revenue cycle departments.
How the 2027 Changes May Affect Outpatient Billing
The finalized OPPS and ASC policies can influence several parts of the revenue cycle.
Hospitals and ambulatory surgery centers should evaluate their existing workflows to identify where payment changes require operational adjustments.
Reimbursement Calculations and Fee Schedule Updates
Updated payment rates and procedure classifications must be reflected in reimbursement estimates and billing systems.
Outdated payment references can create incorrect financial projections and make it harder to identify underpayments.
Facilities should review their most frequently billed outpatient services, identify affected codes, and compare expected 2027 reimbursement with current payment data.
Procedure Scheduling and Service Eligibility
The removal of 637 procedures from the IPO list and addition of 618 codes to the ASC Covered Procedures List may influence outpatient service planning.
Facilities should review which procedures are newly eligible and determine whether their clinical and operational capabilities support providing them.
Scheduling teams should coordinate with physicians, clinical departments, and billing staff to confirm the appropriate setting and applicable coverage requirements.
Drug Billing and 340B Documentation
Hospitals participating in the 340B program need accurate drug acquisition information and appropriate claim reporting.
Billing teams should distinguish applicable 340B-acquired drugs from non-340B drugs and confirm whether exemptions apply.
The new payment methodology makes accurate documentation and reconciliation particularly important.
Prior Authorization and Claim Submission
The expansion of prior authorization requirements for certain botulinum toxin injections creates additional front-end responsibilities for affected hospitals.
Authorization teams should verify requirements before services are performed and ensure the authorization information is available to billing staff.
The procedure, date of service, provider, and other relevant claim details should be consistent with the approved request.
Accounts Receivable and Payment Reconciliation
Payment changes can create discrepancies between expected and actual reimbursement.
Facilities should review Medicare remittance advice, identify underpayments, and investigate differences involving payment classifications, drug modifiers, and procedure eligibility.
Consistent A/R follow-up can help organizations identify unresolved claims and prevent payment discrepancies from remaining unnoticed.
8 Steps Hospitals and ASCs Should Take Before the 2027 Changes
Preparing for the new Medicare payment policies requires coordination between financial, clinical, compliance, and billing teams.
The following steps can help outpatient organizations improve readiness.
1. Review the Final CMS Payment Rule
Use the finalized CY 2027 OPPS and ASC rule rather than relying on earlier proposed policies.
Identify the provisions that directly affect your facility, service lines, and Medicare patient population.
2. Review Updated Payment Files and Procedure Codes
Examine the finalized payment classifications, covered procedure lists, and applicable code updates.
Identify services that may experience reimbursement changes and update internal payment references.
3. Analyze Your 340B Drug Billing Process
If your facility participates in the 340B program, review drug acquisition documentation, exemption eligibility, claim modifiers, and reimbursement calculations.
Make sure the appropriate billing information is available to the staff responsible for drug claims.
4. Evaluate the Expanded ASC Procedure List
ASCs should review the 618 newly added codes and determine which services are relevant to their specialties and operational capabilities.
Confirm clinical eligibility, equipment requirements, staffing needs, and applicable Medicare coverage conditions.
5. Update Imaging Reimbursement Workflows
Affected off-campus hospital outpatient departments should identify imaging codes subject to the site-neutral payment policy.
Review location-specific reimbursement expectations and ensure billing systems apply the correct payment methodology.
6. Prepare for Additional Authorization Requirements
Affected hospitals should incorporate the new botulinum toxin injection requirements into their authorization workflows before July 1, 2027.
Train staff to identify affected services and maintain complete authorization records.
7. Coordinate Compliance and Enrollment Preparations
Hospitals with applicable off-campus departments should begin reviewing NPI and provider-based attestation requirements ahead of January 1, 2028.
Coordinate with enrollment, compliance, and billing departments to avoid last-minute administrative issues.
8. Conduct Regular Billing and Reimbursement Audits
Review claims for incorrect codes, missing modifiers, inaccurate payment classifications, and reimbursement discrepancies.
Regular audits can help identify billing weaknesses before they affect a larger volume of claims.
The Medicator's medical billing audit services can support practices and healthcare organizations seeking to identify billing errors and improve revenue cycle accuracy.
Common OPPS and ASC Billing Mistakes to Avoid in 2027
Changes to Medicare payment policies can create new opportunities, but incorrect implementation can also result in reimbursement problems.
Outpatient facilities should watch for these common issues:
Using outdated payment rates: Applying 2026 payment information to 2027 services can result in inaccurate reimbursement calculations.
Incorrect 340B drug reporting: Failure to distinguish drug acquisition status or apply the appropriate modifier can affect reimbursement and compliance.
Assuming every removed IPO procedure is automatically covered: Clinical appropriateness and other Medicare coverage requirements still apply.
Ignoring ASC procedure eligibility requirements: A newly added code does not remove the need to verify patient suitability, coverage, and facility requirements.
Missing prior authorization: Affected botulinum toxin injection services require attention to the July 2027 implementation date.
Applying incorrect imaging payment rates: Facilities should verify whether their locations and imaging services are affected by the site-neutral policy.
Failing to review Medicare remittance advice: Payment discrepancies may remain unresolved when billing teams do not compare expected and actual reimbursement.
Delaying administrative preparation: Hospitals with affected off-campus departments should not wait until 2028 to begin reviewing their NPI and attestation requirements.
How The Medicator's Supports Medical Billing and Revenue Cycle Management
Managing Medicare outpatient billing changes requires accurate coding, organized claim submission, consistent payer follow-up, and reliable financial reporting.
The Medicator's provides medical billing and revenue cycle management support designed to help healthcare providers strengthen billing operations and improve reimbursement visibility.
Our services include:
Medical Billing and Coding
Accurate coding and claim preparation help healthcare organizations maintain consistent billing processes and reduce preventable submission errors.
Revenue Cycle Management
Coordinated revenue cycle support helps manage administrative and financial activities from patient registration and eligibility verification through claims processing and reimbursement follow-up.
Denial Management
Identifying denial patterns, reviewing claim errors, and coordinating appropriate follow-up can help healthcare organizations address preventable reimbursement delays.
A/R Management
Consistent payer follow-up helps identify outstanding claims, investigate payment discrepancies, and maintain better visibility into accounts receivable.
Eligibility Verification
Verifying patient coverage and applicable benefits before services are provided can help reduce front-end billing problems.
Medical Billing Audits
Billing audits can help identify coding inconsistencies, missing charges, documentation gaps, and other issues that affect reimbursement accuracy.
Explore our medical billing services and revenue cycle management services to learn how structured billing support can help your organization manage changing reimbursement requirements.
Prepare for 2027 Medicare Outpatient Billing Changes
The 2027 OPPS and ASC final rule introduces important changes to outpatient reimbursement, drug payment policies, procedure eligibility, imaging services, and prior authorization.
Hospitals and ambulatory surgery centers should review the finalized requirements, update payment configurations, train staff, and monitor reimbursement accuracy as the new policies take effect.
The Medicator's supports healthcare providers with medical billing, coding, denial management, A/R follow-up, and revenue cycle management.
If your organization wants to strengthen its billing processes and improve financial visibility, contact The Medicator's to discuss your revenue cycle needs.
Taking You Forward.
Frequently Asked Questions
What are the major Medicare OPPS changes for 2027?
Major changes include a 2.3% payment update for qualifying facilities, revised reimbursement for certain 340B-acquired drugs, expanded site-neutral imaging payments, removal of 637 procedures from the Inpatient Only list, and additional prior authorization requirements.
What is the 2027 Medicare ASC payment update?
CMS finalized a 2.3% update to ASC payment rates for facilities meeting applicable quality reporting requirements. Actual reimbursement varies according to the applicable procedure, payment classification, and other Medicare adjustments.
How does the 2027 rule affect 340B drug reimbursement?
Applicable separately payable 340B-acquired outpatient drugs will generally be reimbursed at ASP minus 28%, subject to finalized exemptions and other applicable requirements.
How many procedures were removed from the Medicare Inpatient Only list in 2027?
CMS finalized the removal of 637 services from the Inpatient Only list for 2027. These services may qualify for outpatient payment when applicable clinical and coverage requirements are satisfied.
How many new codes were added to the ASC Covered Procedures List?
CMS added 618 codes to the ASC Covered Procedures List for 2027, expanding the range of procedures that may qualify for Medicare payment in eligible ambulatory surgery centers.
When do the new botulinum toxin prior authorization requirements begin?
The expanded prior authorization requirements for applicable botulinum toxin injection codes apply to dates of service on or after July 1, 2027.
What are the new NPI requirements for off-campus hospital departments?
Beginning January 1, 2028, applicable off-campus hospital outpatient departments must obtain separate NPIs and provide required attestations regarding provider-based compliance as a condition for Medicare payment under the finalized policy.
How can outpatient facilities prepare for the 2027 Medicare payment changes?
Facilities should review the final rule, update payment files and billing systems, assess procedure eligibility, review 340B drug reporting, prepare for authorization requirements, train staff, and monitor Medicare reimbursement.
How can The Medicator's help with outpatient medical billing?
The Medicator's provides medical billing, coding, eligibility verification, denial management, A/R management, billing audits, and revenue cycle management support to help healthcare organizations maintain accurate billing operations.
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Jocuri
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Alte
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness